LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-57 Cr | ₹-37 Cr | ₹-78 Cr | ₹-64 Cr | ₹-31 Cr |
What is the latest Cash Flow from Investing Activities ratio of LINCOLN PHARMACEUTICALS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-57 Cr |
Mar2023 | ₹-37 Cr |
Mar2022 | ₹-78 Cr |
Mar2021 | ₹-64 Cr |
Mar2020 | ₹-31 Cr |
How is Cash Flow from Investing Activities of LINCOLN PHARMACEUTICALS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-57 Cr | Negative | |
Mar2023 | ₹-37 Cr | Negative | |
Mar2022 | ₹-78 Cr | Negative | |
Mar2021 | ₹-64 Cr | Negative | |
Mar2020 | ₹-31 Cr | - |
Compare Cash Flow from Investing Activities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,093.4 Cr | -0.2% | -4.5% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.2% |
-4.5% |
-6.6% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses